Sort by
Refine Your Search
-
Category
-
Field
-
and their scientific and teaching supervision capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO
-
process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile: R3/R4 R3 Established researcher A stage in
-
to design a completely new material to meet a need identified by clinicians, and to conduct its preclinical and clinical evaluation in-house, enabling a rapid and efficient process. For example, we can design
-
selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd Researcher Profile: R3/R4
-
their scientific and teaching supervision capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO
-
the widespread use of antiplatelet drugs, which target only some of the mechanisms involved, this process continues to affect patients, revealing the limitations of current therapies. Infections significantly
-
participate in this major movement for the Life Sciences. Strategy of the host laboratory: The junior professor will join the Laboratory for Optics and Biosciences Laboratory (LOB), a joint Inserm-CNRS Physics
-
capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education Level: Phd
-
supervision capacity. The candidates selected at the end of the selection process will be offered a researcher contract, following approval from the President and CEO of Inserm. Required profile: Education
-
details in https://umr-right.com ). Summary of the scientific project: The maintenance of T cell effector functions in vivo are critical for the success of cancer immunotherapies including Immune checkpoint